Recent stock trades by two U.S. congressmen have reignited debates over the ethics of lawmakers engaging in stock market activities. Representatives James Comer (R-KY) and Gilbert Ray Cisneros (D-CA) purchased shares of Palantir Technologies (NYSE: PLTR) shortly before a significant surge in the company’s stock price.
Strategic Investments by Lawmakers
- James Comer: Serving as the chair of the House Committee on Oversight and Accountability, Comer acquired Palantir shares on January 21.
- Gilbert Ray Cisneros: A member of the House Committee on Armed Services, Cisneros made his purchase on January 24.
Both transactions were valued between $1,001 and $15,000. Given Palantir’s significant involvement in defense contracts and government intelligence operations, their committee roles might have provided them with insights not readily available to the public.
WOW.
TWO members of Congress just disclosed $PLTR purchases stock this morning.
The trades were both made in late January. The stock is up over 50% since then.
We had never seen a politician buy Palantir stock before today. pic.twitter.com/cDQPqeKz2Y— Quiver Quantitative (@QuiverQuant) February 12, 2025
Palantir’s Stock Performance
Following these purchases, Palantir’s stock experienced notable gains:
- Comer’s Investment: Increased by approximately 58.84%.
- Cisneros’s Investment: Rose by around 46.96%.
As of the latest data, Palantir’s stock is trading at $116.07, reflecting a 53.47% increase year-to-date.
The Defense Connection
Palantir is renowned for its AI-driven defense and intelligence solutions and has secured major government contracts:
- Cisneros’s Position: His role on the Armed Services Committee may provide insights into forthcoming defense contracts, a significant revenue source for Palantir.
- Comer’s Role: As chair of the Oversight and Accountability Committee, he has access to discussions on government technology, cybersecurity, and AI innovations, all pertinent to Palantir’s operations.
Ethical Considerations
The capacity of lawmakers to trade stocks while overseeing the industries they invest in has long been a contentious issue. Critics argue that such practices can lead to conflicts of interest, given their access to non-public information.
This incident has intensified discussions about potential insider trading, the adequacy of disclosure rules, and the enforcement of penalties for violations. There is a growing call for legislation, such as the Bipartisan Ban on Congressional Stock Trading Act, to prohibit lawmakers from trading individual stocks while in office.
As scrutiny increases, the central question remains: Should members of Congress be restricted from participating in the stock market during their tenure?
Related:
Hottest CPI inflation report: What does this mean for FED rate cut?
Super Micro (SMCI) Surges After Filing Update—Can It Recover From Its Accounting Scandal?
Rocket Labs (RKLB) vs Intuitive Machines (LUNR): The Likely Winner in 2025?
Physical Gold BUYING Went Apocalyptic: What to Expect
Short positioning in Ethereum is now up +40% in ONE WEEK: What do hedge funds know is coming?
Elon Musk and Coinbase’s CEO proposed putting ALL US spending on blockchain. What does this mean?
Trump’s 25% Tariffs on Steel & Aluminum: What It Means for Stocks
Top Funds Absolutely Adore These 6 Stocks — And Love Tesla, Too
Trump to Announce Reciprocal Tariffs: Is a New Stock Dip Coming?
Key Events to Watch in [Week] & Their Market Impact
Bullish Momentum vs. Financial Reality in Palantir
Here Are 10 Most Polarizing Stocks in Market Right Now & Why Critics Might Be Wrong